Skip to main content

Goldenwell Biotech, Inc.

GWLL
Exchange
OTC
Industry
Food and Kindred Products
SEC CIK
0001800373

No open-market purchases or sales by Goldenwell Biotech, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of GWLL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Goldenwell Biotech, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Goldenwell Biotech, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Goldenwell Biotech, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GWLL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 10, 2023Wang James L.13GOld format–New–SEC
May 23, 2023Liu Shuang13DOld format–New–SEC
May 23, 2023Yang Li13DOld format–New–SEC
May 23, 2023Xie Hua13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Goldenwell Biotech, Inc. shares.

No Form 144 notices for Goldenwell Biotech, Inc. are on file.